What Sir Chris Hoy's Story Can Teach Us About Prostate Cancer

On screen

Sir Chris Hoy, the six-time Olympic gold medal track cyclist, shared publicly in early 2024 that he was being treated for cancer. Later that year he revealed more: he had stage 4 prostate cancer that had spread to his bones, and doctors had told him it could not be cured. He was in his late forties — younger than many people expect for this disease.

What happened next says a lot about him. Rather than stepping back, Hoy became one of the UK's most visible advocates for prostate cancer awareness. In the two days after his announcement, visits to the NHS webpage on prostate cancer symptoms rose by more than 670 percent. He has since launched the Tour de 4 charity ride — which raised more than £3 million in its first year in 2025 — supported a Scottish initiative that drew thousands of men to sign up for risk checks within days, and, as of early 2026, has described his own condition as stable while continuing treatment. We share only what he has chosen to make public, and we do not speculate about his private care.

The reality

According to the National Cancer Institute, prostate cancer is the most common cancer and the second leading cause of cancer death among men in the United States. NCI notes that prostate cancer usually grows very slowly, and that finding and treating it before symptoms occur may not always improve a man's health or help him live longer. But not every prostate cancer behaves that way — some are more aggressive, and in some cases the cancer spreads (metastasizes) to other parts of the body, such as bone. Cancer that spreads is still named for where it began, so prostate cancer in the bones is still prostate cancer.

What the story gets right — and what to remember

Hoy's openness shows something real: a stage 4 diagnosis is life-changing, but it is not the end of living. He has continued to ride, raise money, and speak publicly about redefining what life with advanced cancer can look like. At the same time, his situation is his own. Prostate cancer ranges from very slow-growing to aggressive, and one person's diagnosis, stage, and treatment do not predict anyone else's. His story is a reason to learn and to talk with a doctor — not a forecast, and not medical advice.

Awareness, screening & prevention

NCI explains that there is no standard or routine screening test for prostate cancer. The prostate-specific antigen (PSA) blood test can help detect it, but screening has both possible benefits and possible harms, so most medical organizations recommend that men discuss the decision with their doctor first. NCI also notes that some organizations do recommend routine PSA testing starting at age 40 or 45 for men at higher risk — including Black men, men with certain inherited BRCA gene variants, and men whose father or brother had prostate cancer. That conversation is exactly what Hoy has been encouraging men to have. You can read more in our plain-language guide to prostate cancer screening, and if you are not sure which screening conversations fit your age and history, our free screening check-up tool is a gentle place to start.

Turning a story into something useful

When someone as strong and seemingly healthy as an Olympic champion shares a diagnosis like this, it reaches people that statistics never could. A useful response is calm and practical: learn what prostate cancer is, know whether your age or family history puts you at higher risk, and bring the question to a healthcare team. Sharing accurate, non-alarming information — and supporting free cancer education — carries Hoy's advocacy forward.

Questions to ask a healthcare team

• Given my age, family history, and background, should I consider PSA testing?
• What are the possible benefits and harms of prostate cancer screening for me?
• What symptoms or changes would be worth reporting between visits?
• If prostate cancer were found, what would the stage and test results mean?